Genmab — Oktober 2020
-
uciano J Costa
@End_myeloma
·
8 t
Accrual completed for 123 patients on MASTER study with enrichment for high risk #mmsm!! I am most proud of the collaboration fostered in the COMMIT consortium. 20% patients 70 or older, 24% minorities. We "COMMIT" to 25%+ minorities in future trials.https://twitter.com/End_myeloma/status/1315754304586674176/photo/1 -
Scottish medicines consortium accept Dara sc. https://m.firstwordpharma.com/scottish-medicines-consortium-accepts-darzalex-daratumumab-subcutaneous-injection-and-imbruvica
-
-
FDA grants orphan drug designation to natural killer cell therapy for multiple myeloma: https://www.healio.com/news/hematology-oncology/20201012/fda-grants-orphan-drug-designation-to-natural-killer-cell-therapy-for-multiple-myeloma
-
CD37：/ Genmab for the chinese speakers
https://www.medsci.cn/article/show_article.do?id=91e0201983b1
-
COMy 2020 | The benefits of bispecific antibodies for treating multiple myelomahttps://www.vjhemonc.com/video/f0qq0rqeev8-the-benefits-of-bispecific-antibodies-for-treating-multiple-myeloma/
-
-88% er vel ikke at "blive handlet ned"?
-
Der skete noget ....
-
1099M USD
-
Bedre end consensus
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind